Martin L. Olsson

(He/Him)

1

Article

0

Comments
  • Medical Director of the Nordic Reference Laboratory for Blood Group Genomics, Region Skåne & Professor and Head of Division of Transfusion Medicine, Lund University

Martin L. Olsson, M.D., Ph.D., is a Professor of Transfusion Medicine at Lund University and Medical Director of the Nordic Reference Laboratory for Blood Group Genomics at Region Skåne in Lund, Sweden. His clinical and research interests revolve around the biology of the red blood cell in health and disease, with a special focus on the genetics, structure and function of blood group molecules.

Experience

  • 2000–present
    Consultant (Överläkare), University Hospital Blood Centre, Lund, Sweden
  • 2001–present
    Medical Director, Nordic Reference Laboratory for Blood Group Genomics, Region Skåne, Sweden
  • 2023–present
    President, Swedish Society of Clinical Immunology and Transfusion Medicine
  • 1999–present
    Associate Professor (Docent), Lund University, Lund, Sweden
  • 2006–present
    Professor of Transfusion Medicine, Lund University, Lund, Sweden
  • 2023–2026
    Chair of the Joint Steering Committee, Interreg EU Project HALRIC, coordinated by Lund University
  • 2023–2026
    Chair of the Board, Lund University ATMP (cell, gene and tissue) Center
  • 2021–2023
    Deputy Dean, Faculty of Medicine, Lund University, Lund, Sweden
  • 2018–2020
    Vice Dean of Research Infrastructure, Faculty of Medicine, Lund University, Lund, Sweden
  • 2018–2020
    President, Chair of the Board, International Society of Blood Transfusion, Amsterdam, The Netherlands
  • 2003–2008
    Visiting Associate Professor, Harvard Medical School, Beth Israel Deaconess Medical Center, Dept. of Pathology
  • 1992–1998
    Residency in Transfusion Medicine (ST-läkare), University Hospital Blood Centre, Lund, Sweden
  • 1996–1996
    Visiting researcher, International Blood Group Reference Laboratory, Bristol, UK
  • 1991–1992
    Internship (AT-läkare), Karlskrona Regional Hospital, Blekinge Läns Landsting, Sweden

Education

  • 1997 
    Lund University, Ph.D.
  • 1991 
    Lund University, M.D.

Grants and Contracts

  • 2025
    The Polymorphic Red Blood Cell Surface: For Safer Transfusions and a Role as Regulator of Hematopoiesis, Host-Pathogen Interactions and Hemostasis
    Role:
    Principal Investigator
    Funding Source:
    Swedish Research Council
  • 2023
    Extended ABO antigens: The missing link towards universal donor blood
    Role:
    Co-Applicant
    Funding Source:
    Novo Nordisk Foundation
  • 2023
    The Polymorphic Red Blood Cell Surface as a Regulator of Hematopoiesis, Hemolysis and Hemostasis
    Role:
    Principal Investigator
    Funding Source:
    Swedish Governmental Grants to University Healthcare Regions (ALF)
  • 2022
    The Polymorphic Red Blood Cell Surface as a Regulator of Hematopoiesis, Host-Pathogen Interactions and Hemostasis
    Role:
    Principal Investigator
    Funding Source:
    Knut och Alice Wallenberg Foundation

Professional Memberships

  • American Society of Hematology
  • International Society of Blood Transfusion (Honorary Member)
  • Association for the Advancement of Blood and Biotherapies (USA)
  • Swedish Society of Clinical Immunology and Transfusion Medicine (Board Member)
  • Swedish Society of Medicine

Honours

Numerous national and international awards and honours, see https://portal.research.lu.se/en/persons/martin-l-olsson/prizes/

Contact Martin for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision